Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose Elevations
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Behavioral: GEM
- Registration Number
- NCT02432391
- Lead Sponsor
- University of Virginia
- Brief Summary
The purpose of this study is to determine if a lifestyle modification program (GEM) that focuses on reducing after-meal blood glucose elevations can improve blood glucose control in people with type 2 diabetes. Half of the participants will continue their routine medical care, and half will receive five sessions of GEM in addition to their routine care. The two groups will be assessed using diabetes-relevant medical, behavioral and psychological measures.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 47
- Diagnosed with type 2 diabetes within the past 5 years
- Age >24 and <80 years
- HbA1c >7.0%
- Approval of primary care physician to participate
- Currently using, or used within the last 3 months, medications that directly lower BG (e.g., insulin, sulfonylureas, glinides, or DPP-4 inhibitors).
- Currently using, or used within the last 3 months, thiazides at doses above HCTZ 25 mg or equivalent, or loop diuretics above furosemide 20mg or equivalent.
- Currently pregnant or contemplating pregnancy in the coming year
- Currently using, or used within the last 3 months, medications that impede weight loss (e.g., prednisone)
- Having conditions that preclude increasing physical activity, e.g. severe neuropathy, active cardiovascular disease, emphysema, osteoarthritis, stroke.
- Undergoing cancer treatment
- History of lactic acidosis
- Diagnosed with renal impairment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description GEM GEM Participants receive the GEM (Glycemic load, Exercise, and Monitoring blood glucose) lifestyle modification program and continue their routine medical care for type 2 diabetes.
- Primary Outcome Measures
Name Time Method Change from baseline glycosylated hemoglobin at 6 months 0 and 6 months HbA1c
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Virginia
🇺🇸Charlottesville, Virginia, United States